Exact Mass: 257.1016

Exact Mass Matches: 257.1016

Found 37 metabolites which its exact mass value is equals to given mass value 257.1016, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

5-Methylcytidine

5-Methylcytidine

C10H15N3O5 (257.1012)


CONFIDENCE standard compound; INTERNAL_ID 322 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.054 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.053 5-Methylcytidine is a pyrimidine nucleoside detected in multiple biofluids. 5-Methylcytidine is a pyrimidine nucleoside detected in multiple biofluids.

   

5-Methylcytidine

4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2-dihydropyrimidin-2-one

C10H15N3O5 (257.1012)


5-Methylcytidine belongs to the class of organic compounds known as pyrimidine nucleosides. Pyrimidine nucleosides are compounds comprising a pyrimidine base attached to a ribosyl or deoxyribosyl moiety. 5-Methylcytidine is a post-transcriptional modifications found in tRNA, snRNA, and rRNA. It is associated with the genetic change which is involved in the origin of cancer (PMID 6260434). [HMDB] 5-Methylcytidine is a pyrimidine nucleoside detected in multiple biofluids. 5-Methylcytidine is a pyrimidine nucleoside detected in multiple biofluids.

   

Pyro-L-glutaminyl-L-glutamine

(2S)-4-carbamoyl-2-{[(2S)-5-oxopyrrolidin-2-yl]formamido}butanoic acid

C10H15N3O5 (257.1012)


Pyro-L-glutaminyl-L-glutamine is found in fruits. Pyro-L-glutaminyl-L-glutamine is a constituent of the seeds of Dolichos biflorus (papadi). Constituent of the seeds of Dolichos biflorus (papadi). Pyro-L-glutaminyl-L-glutamine is found in fruits.

   

3-Methylcytidine

3-Methylcytidine

C10H15N3O5 (257.1012)


3-Methylcytidine belongs to the class of organic compounds known as pyrimidine nucleosides. These are compounds comprising a pyrimidine base attached to a ribosyl or deoxyribosyl moiety. 3-Methylcytidine is a potential urinary biomarker of whole grain intake (PMID: 27805021). 3-Methylcytidine has been identified in the human placenta (PMID: 32033212). 3-Methylcytidine, a urinary nucleoside, can be used as a biomarker of four different types of cancer: lung cancer, gastric cancer, colon cancer, and breast cancer[1].

   

1-[(2S,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-imino-3-methylpyrimidin-2-one

1-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-imino-3-methyl-1,2,3,4-tetrahydropyrimidin-2-one

C10H15N3O5 (257.1012)


   

2'-O-Methylcytidine

1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-4-imino-1,4-dihydropyrimidin-2-ol

C10H15N3O5 (257.1012)


2'-O-Methylcytidine is a 2'-substituted nucleoside as a inhibitor of HCV replication. 2'-O-Methylcytidine inhibits RNA-dependent RNA polymerase (NS5B)-catalyzed RNA synthesis in vitro, in a manner that is competitive with substrate nucleoside triphosphate[1].

   

2'-C-Methylcytidine

4-amino-1-(3,4-dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidin-2(1H)-one

C10H15N3O5 (257.1012)


   

benserazide

2-amino-3-hydroxy-N-[(2,3,4-trihydroxyphenyl)methyl]propanehydrazonic acid

C10H15N3O5 (257.1012)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor

   

4-Amino-1-[(2R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidin-2-one

4-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2-dihydropyrimidin-2-one

C10H15N3O5 (257.1012)


   

benserazide

2-Amino-3-hydroxy-2-(2,3,4-trihydroxybenzyl)propionohydrazide

C10H15N3O5 (257.1012)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor CONFIDENCE standard compound; EAWAG_UCHEM_ID 2853

   

2-deoxy-5-(hydroxymethyl)cytidine

2-deoxy-5-(hydroxymethyl)cytidine

C10H15N3O5 (257.1012)


   
   

SCHEMBL16359927

SCHEMBL16359927

C10H15N3O5 (257.1012)


   

3-Methylcytidine

3-Methylcytidine

C10H15N3O5 (257.1012)


3-Methylcytidine, a urinary nucleoside, can be used as a biomarker of four different types of cancer: lung cancer, gastric cancer, colon cancer, and breast cancer[1].

   

5-Hydroxymethyldeoxycytidin|O5-hydroxymethyl-2-deoxy-cytidine

5-Hydroxymethyldeoxycytidin|O5-hydroxymethyl-2-deoxy-cytidine

C10H15N3O5 (257.1012)


   

N-(beta-Glutaminylaminoethyl)-2H-Oxo-5(4H)-Isoxazolone

N-(beta-Glutaminylaminoethyl)-2H-Oxo-5(4H)-Isoxazolone

C10H15N3O5 (257.1012)


   

2-O-Methylcytidine

2′-O-methylcytidine

C10H15N3O5 (257.1012)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.053 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.052 2'-O-Methylcytidine is a 2'-substituted nucleoside as a inhibitor of HCV replication. 2'-O-Methylcytidine inhibits RNA-dependent RNA polymerase (NS5B)-catalyzed RNA synthesis in vitro, in a manner that is competitive with substrate nucleoside triphosphate[1].

   

3-O-Methylcytidine

3-(O-METHYL)CYTIDINE

C10H15N3O5 (257.1012)


3′-O-Methylcytidine is a cytidine analog. Cytidine analogs have a mechanism of inhibiting DNA methyltransferases (such as Zebularine, HY-13420), and have potential anti-metabolic and anti-tumor activities[1].

   

5-Methyluridine

5-Methyluridine

C10H15N3O5 (257.1012)


   

5-Hydroxymethyl-deoxycytidine

5-Hydroxymethyl-deoxycytidine

C10H15N3O5 (257.1012)


   

5-Methyl-cytidine

5-Methyl-cytidine

C10H15N3O5 (257.1012)


   

Pyro-L-glutaminyl-L-glutamine

4-carbamoyl-2-[(5-oxopyrrolidin-2-yl)formamido]butanoic acid

C10H15N3O5 (257.1012)


   

trimethyl-[(3-trimethylsilyloxy-1,2,4-triazin-5-yl)oxy]silane

trimethyl-[(3-trimethylsilyloxy-1,2,4-triazin-5-yl)oxy]silane

C9H19N3O2Si2 (257.1016)


   

ethene,(Z)-4-ethoxy-4-oxobut-2-enoic acid,2-methylprop-2-enoate

ethene,(Z)-4-ethoxy-4-oxobut-2-enoic acid,2-methylprop-2-enoate

C12H17O6- (257.1025)


   

2-C-Methylcytidine

2-C-Methylcytidine

C10H15N3O5 (257.1012)


NM107 (2'-C-Methylcytidine) is an nucleoside inhibitor of the hepatitis C virus (HCV) NS5B polymerase, the EC50 of NM107 in the wild-type replicon cells is 1.85 μM[1][2].

   

5-Methylisocytidine

5-Methylisocytidine

C10H15N3O5 (257.1012)


   

4-Amino-5-methyl-1-pentofuranosyl-2(1h)-pyrimidinone

4-Amino-5-methyl-1-pentofuranosyl-2(1h)-pyrimidinone

C10H15N3O5 (257.1012)


   

4-Amino-1-[4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]pyrimidin-2-one

4-Amino-1-[4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]pyrimidin-2-one

C10H15N3O5 (257.1012)


   

N4-Methylcytidine

N4-Methylcytidine

C10H15N3O5 (257.1012)


N4-Methylcytidine (Nsc518744) is a cytidine nucleoside analog. Cytidine analogs have a mechanism of inhibiting DNA methyltransferases (such as Zebularine, HY-13420), and have potential anti-metabolic and anti-tumor activities[1].

   

5-amino-5-oxo-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]pentanoic acid

5-amino-5-oxo-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]pentanoic acid

C10H15N3O5 (257.1012)


   

Pyroglutamylglutamine

Pyroglutamylglutamine

C10H15N3O5 (257.1012)


A dpeptide obtained by formal condensation of the carboxy group of L-pyroglutamine with the amino group of L-glutamine

   
   

O-Methylcytidine

O-Methylcytidine

C10H15N3O5 (257.1012)


   
   

(2s)-2-amino-4-{[2-(5-oxo-1,2-oxazol-2-yl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

(2s)-2-amino-4-{[2-(5-oxo-1,2-oxazol-2-yl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C10H15N3O5 (257.1012)


   

2-amino-4-{[2-(5-oxo-1,2-oxazol-2-yl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

2-amino-4-{[2-(5-oxo-1,2-oxazol-2-yl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C10H15N3O5 (257.1012)